Pfizer Diflucan switch for vaginal yeast infections proposed in U.K..
This article was originally published in The Tan Sheet
Executive Summary
DIFLUCAN SWITCH TO NONPRESCRIPTION STATUS IN U.K. PROPOSED by the Medicines Control Agency for the one-day treatment of vaginal yeast infec-tions. Pfizer received prescription approval for the use of a one-day treatment regimen with Diflucan (fluconazole) in the U.S. last summer ("The Tan Sheet" July 11, 1994, p. 8).